KRAS(G12V)/HLA-A*02:01-targeted chimeric antigen receptor T cells exhibit potent preclinical activity against solid tumors.
靶向 KRAS(G12V)/HLA-A*02:01 的嵌合抗原受体 T 细胞对实体瘤表现出强大的临床前活性。
期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.aea2511
Shao Huimin, Xu Fei, Xu Jiangyue, Zhou Lingjie, Wu Yao, He Lianjun, Qian Xueyi, He Weijie, Jiao Nanlin, Xia Yabin, Zhao Jun, Sheng Lili, Mao Guoliang, Ma Tao, Wang Wei, Luo Shaoxiang, Fu Li, Xu Zhenyu